These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 19705971)

  • 1. Uncontrolled HIV RNA, immunodeficiency, and malignancy: implications for cancer control.
    Serraino D
    Clin Infect Dis; 2009 Oct; 49(7):1117-8. PubMed ID: 19705971
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer risk in HIV-infected persons: influence of CD4(+) count.
    Clifford GM; Franceschi S
    Future Oncol; 2009 Jun; 5(5):669-78. PubMed ID: 19519206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous control of viral replication during primary HIV infection: when is "HIV controller" status established?
    Goujard C; Chaix ML; Lambotte O; Deveau C; Sinet M; Guergnon J; Courgnaud V; Rouzioux C; Delfraissy JF; Venet A; Meyer L;
    Clin Infect Dis; 2009 Sep; 49(6):982-6. PubMed ID: 19681706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications & side effects. Increase in blood clots found.
    TreatmentUpdate; 2004 Oct; 16(6):7-8. PubMed ID: 17219681
    [No Abstract]   [Full Text] [Related]  

  • 5. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: authors' reply.
    Crum-Cianflone NF; Hullsiek KH; Marconi V; Weintrob A; Ganesan A; Barthel RV; Fraser S; Agan BK
    AIDS; 2009 Aug; 23(13):1791-2. PubMed ID: 19684484
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relationship between psychological distress and T lymphocyte in HIV/AIDS patients].
    Lu SH; Tang XP; Deng XL; Chen WL; Hu RX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Feb; 23(1):23-5. PubMed ID: 19799009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution.
    Murdaca G; Contini P; Setti M; Cagnati P; Lantieri F; Indiveri F; Puppo F
    Clin Immunol; 2009 Nov; 133(2):238-44. PubMed ID: 19762282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Durable response to a single dose of Anti D in immune thrombocytopenic purpura in an adult with underlying human immunodeficiency viral infection.
    Hewamana S; Pepper C; Karunanithi K; Jenkins C; Rowntree C
    Ann Hematol; 2009 Nov; 88(11):1155-6. PubMed ID: 19399500
    [No Abstract]   [Full Text] [Related]  

  • 9. StatBite: Cancer incidence among HIV-infected individuals in the U.S., 2000-2003.
    J Natl Cancer Inst; 2008 Sep; 100(17):1199. PubMed ID: 18728278
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV and your immune system. How they work and why it's important.
    Cervio JS
    Posit Aware; 2009; 20(5):17-21. PubMed ID: 19785102
    [No Abstract]   [Full Text] [Related]  

  • 11. Routine HIV screening, Part 2: beyond testing and referral.
    Gallant JE
    AIDS Read; 2009; 19(6):211-2. PubMed ID: 19642238
    [No Abstract]   [Full Text] [Related]  

  • 12. Brazilian HIV-infected population: assessment of the needs of endodontic treatment in the post-highly active antiretroviral therapy era.
    de Brito LC; da Rosa MA; Lopes VS; e Ferreira EF; Vieira LQ; Sobrinho AP
    J Endod; 2009 Sep; 35(9):1178-81. PubMed ID: 19720212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
    J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumocystis-associated organizing pneumonia as a manifestation of immune reconstitution inflammatory syndrome in an HIV-infected individual with a normal CD4+ T-cell count following antiretroviral therapy.
    Mori S; Polatino S; Estrada-Y-Martin RM
    Int J STD AIDS; 2009 Sep; 20(9):662-5. PubMed ID: 19710347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virology. Moving forward in HIV vaccine development.
    Letvin NL
    Science; 2009 Nov; 326(5957):1196-8. PubMed ID: 19965456
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of anti retroviral therapy (ART) on CD4 T lymphocyte count and the spectrum of opportunistic infections in HIV/AIDS in Manipur.
    Chitra Y; Urgen S; Dayananda I; Brajachand SN
    J Commun Dis; 2009 Mar; 41(1):19-24. PubMed ID: 19886171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemic of cancers feared with HIV link.
    AIDS Read; 2009 Jan; 19(1):8. PubMed ID: 19213098
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV-infected patients with a large thymus maintain higher CD4 counts in a 5-year follow-up study of patients treated with highly active antiretroviral therapy.
    Kolte L; Ryder LP; Albrecht-Beste E; Jensen FK; Nielsen SD
    Scand J Immunol; 2009 Dec; 70(6):608-13. PubMed ID: 19906203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated Russell body duodenitis.
    Savage NM; Fortson T; Schubert M; Chamberlain S; Lee J; Ramalingam P
    Dig Dis Sci; 2011 Jul; 56(7):2202-4. PubMed ID: 21234686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.